Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

09:00 BST DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables

DelSiTech Ltd, a Finnish drug delivery and drug development company, today announced significant grant funding to support the development of...


09:00 BST EPO Revokes Regenlab PRP Patent

Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling...


08:00 BST Debiopharm Expands Its Immuno-oncology Development Program for Debio 1143, With the First IAP Inhibitor/Nivolumab Combination Trial

Debiopharm (www.debiopharm.com) announced today the first patient enrolled in SMARTPLUS-106, an exploratory study investigating the safety and...


08:00 BST DSM - Repurchase of Shares (13 - 17 May 2019)

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 222,500 of its own shares in the period from...


07:23 BST Oncopeptides AB: INTERIM REPORT Q1 2019

"The initiation of the filing process for melflufen in the US is a major milestone for Oncopeptides." Financial overview January 1 – March 31, 2019...


20 May, 2019, 17:14 BST Oncopeptides to Apply for Accelerated Approval in the US

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that, after discussions with the FDA, the company has initiated the preparation for...


20 May, 2019, 17:01 BST BioArctic Receives MEUR 15 Milestone Payment from Eisai for Start of BAN2401 Confirmatory Phase 3 Study in Early Alzheimer's Disease

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company will receive a milestone payment of MEUR 15 from its partner Eisai...


20 May, 2019, 13:05 BST After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will...


20 May, 2019, 13:00 BST Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

Merck, a leading science and technology company, today announced its participation in a collaboration with the Vaccine Formulation Institute and the...


20 May, 2019, 12:12 BST Flexipharm Austrading Announces Launch of Arsenic Trioxide Phebra (Arsenic Trioxide 1mg/ml Concentrate for Solution for Infusion)

Flexipharm Austrading the UK specialty pharmaceutical company focused on supplying the NHS with Better. Critical Care Medicines, today announced the...


20 May, 2019, 09:00 BST Asceneuron Appoints Experienced CNS Clinician Dr Eric Yuen to the Board of Directors

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today...


20 May, 2019, 08:00 BST New Post-hoc Analysis Shows Adding UPTRAVI®▼ (selexipag) Versus Placebo Improved Long-term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatment Effect When Initiated Early

Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has presented results of a post-hoc exploratory...


20 May, 2019, 08:00 BST STORM Therapeutics Extends Series A to GBP 30M (USD 38.43M) with New Investor, Seroba Life Sciences

STORM Therapeutics ("STORM"), the drug discovery company tackling disease through modulating RNA modifying enzymes, today announced that it has...


20 May, 2019, 07:00 BST Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1....


20 May, 2019, 02:30 BST Vitamin D Market Worth $1.7 Billion by 2025 - Exclusive Report by MarketsandMarkets™

According to the new market research report "Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Functional Food &...


17 May, 2019, 14:15 BST Orexo's Closest Upcoming Presentations at Conferences

Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the company will...


17 May, 2019, 13:00 BST Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week

Therachon AG ("Therachon"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative...


17 May, 2019, 12:00 BST Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019

Endo International plc (NASDAQ: ENDP) today announced that clinical data from a Phase 3 investigational study of collagenase clostridium histolyticum ...


17 May, 2019, 07:00 BST Crohn's & Colitis UK and Ampersand Health Partner to Create Innovative App to Help People With Crohn's and Colitis

Ampersand Health and Crohn's & Colitis UK today announce a joint initiative to enable people with Inflammatory Bowel Disease (IBD) to take an active...


16 May, 2019, 21:30 BST Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that it will present data from across its hematology/oncology portfolio and pipeline at the...


16 May, 2019, 21:17 BST NASHNET Expands Into the European Union

NASHNET, powered by The Kinetix Group, has focused its efforts on expanding its reach to the European Union. NAFLD/NASH is an international issue,...


16 May, 2019, 18:40 BST Emirates Medical Group and Bee'ah Conduct High-level Talks With the Department of Health and Social Care in the UK to Bring World-class Healthcare Solutions to the UAE

His Excellency Salim bin Mohamed Al Owais, chairman of the board of directors of Bee'ah; the Middle East's sustainability pioneer and the Emirates...


16 May, 2019, 16:45 BST Annual General Meeting 2019 in Karo Pharma Aktiebolag

The annual general meeting resolved to adopt the income statement and balance sheet for the group and the parent company. The annual general meeting...


16 May, 2019, 16:00 BST ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration

Shanghai ChemPartner a leading global Contract Research Organization (CRO), along with Berkeley Lights, Inc. (BLI), the leader in digital cell...


16 May, 2019, 14:18 BST Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that a total of four abstracts have been accepted for presentation at the 24th Congress of...